Associate Professor Christopher Wilkins, MMS, PhD.
Associate Professor Chris Wilkins is the leader of the drug research team at SHORE & Whariki Research Centre, College of Health, Massey University. Chris Wilkins has research expertise in drug trends, drug markets, public health, and drug policy. Over the past ten years he has completed a range of studies of drug use in New Zealand with particular focus on methamphetamine, cannabis, legal highs, ecstasy and the non-medical use of pharmaceuticals. Chris Wilkins has published numerous journal articles on drug use, contributed to three books and regularly reviews manuscripts for Addiction, the International Journal of Drug Policy, Drug & Alcohol Review and Drug and Alcohol Dependence. Chris Wilkins has been an invited speaker at international meetings convened by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), and at the United States National Institute for Drug Abuse Community Epidemiology Working Group (CEWG). He regularly presents papers at the annual meetings of the International Society for the Study of Drug Policy (ISSDP).
21 November 2016
The New Zealand Police have released the latest New Zealand Arrestee Drug Use Monitoring Programme Report (NZ-ADUM) which is produced by SHORE staff members. The 2015 Report was authored by project leader Chris Wilkins, with Jitesh Prasad, Karl Parker, Helen Moewaka Barnes, Lanuola Asiasiga and Marta Rychert.
April 2016 - release of latest IDMS report
Wilkins, C., Prasad, J., Wong, K., Rychert, M. Recent trends in illegal drug use in New Zealand 2006-2014: Findings from the 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013 and 2014 Illicit Drug Monitoring System (IDMS). Auckland: SHORE and Whariki Research Centre, Massey University. IDMS 2014 Final Report.pdf (6,144 KB)
December 2015 - New Zealand Police release of 2014 NZ-ADUM survey report
The New Zealand Police havereleased the latest New Zealand Arrestee Drug Use Monitoring Programme Report (NZ-ADUM) which is produced by SHORE staff members. The 2014 Report was authored by project Chris Wilkins, Jitesh Prasad, Karl Parker, Marta Rychert and Helen Moewaka Barnes.
selected journal articles
Rychert, M., & Wilkins, C., & Witten, K. (2017). Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances (NPS) (‘legal highs’) in New Zealand. Drug and Alcohol Review, published online 27 Feb, doi: 10.1111/dar.12467 [Abstract]. A405
Lai, F., Wilkins, C., Thai, P., & Mueller, J. (2017). An exploratory wastewater analysis study of drug use in Auckland, New Zealand. Drug and Alcohol Review, published online 12 March, doi: 10.1111/dar.12509 [Abstract]. A404
Rychert, M., & Wilkins, C. (2016). Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, ‘legal highs’) in New Zealand. International Journal of Drug Policy, 37, 90-97. A402
Rychert, M., Wilkins, C., Witten, K. (2017). "Lost in translation": issues with the establishment of a legal market for ‘low risk’ psychoactive products (‘legal highs’) in New Zealand. Drugs: Education, Prevention & Policy, Published online: 02 Feb, doi: 10.1080/09687637.09682017.01282422. A401
Wilkins, C. (2016). The case for medicinal cannabis: where there is smoke there may well be fire [Editorial]. New Zealand Medical Journal, 129, 11-14. A399
Wilkins, C., & Rychert, M. (2017). Recent developments with the New Zealand regulated market approach to 'low risk' psychoactive products. Addiction, 112, 32-39, doi: 10.1111/add.13495. A396.
Rychert, M., & Wilkins, C. (2016). Thirty-one psychoactive plants exempted from New Zealand’s Psychoactive Substances Act 2013. Addiction, published online 23 August, doi: 10.1111/add.13526.
Wilkins, C. (2016). After the legalisation of cannabis: the Cannabis Incorporated Society (CIS) regulatory model for recreational cannabis in New Zealand [Editorial]. New Zealand Medical Journal, 129(1433), 17-20. A378
Wilkins, C., Parker, K., Prasad, J., & Jawalkar, S. (2016). Do police arrestees substitute legal highs for other drugs? International Journal of Drug Policy, 31,74-9. A400
Rychert, M., & Wilkins, C. (2016). What products are considered psychoactive under New Zealand’s regulated legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties. Drug Testing and Analysis, doi: 10.1002/dta.1943. A385
Wilkins, C., Prasad, J., Wong, K., Rychert, M., & Graydon-Guy, T. (2015). An exploratory study of the health harms and utilisation of health services of frequent legal high users under the interim regulated legal high market in central Auckland. New Zealand Medical Journal, 129(1431), 51-58. A384
Rychert, M., & Wilkins, C. (2015). The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution. International Journal of Drug Policy, 26, 1273-1278. doi: 10.1016/j.drugpo.2015.08.006. A372